Search - tctmd.com

Displaying 861 - 880 of 943

Sort: Relevancy | Date

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Daily News

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Michael O'Riordan

May 17, 2016

News Daily News

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

Michael O'Riordan

May 17, 2016

News Daily News

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

Michael O'Riordan

May 17, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

Michael O'Riordan

April 12, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Todd Neale

February 25, 2016

News Daily News

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

Todd Neale

January 20, 2016

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Conference News AHA 2015

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Shelley Wood

November 08, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Conference News ESC 2015

DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use

Caitlin E. Cox

September 01, 2015

News Conference News ESC 2015

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Caitlin E. Cox

August 31, 2015

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

Advertisement

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

TCTMD’s Top 10 Most Popular Stories for April 2016

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Discussion Highlights Merits, Limitations of Small Trials

DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Symic Biomedical Selects Vascular Clinical Candidate

肺栓塞发作后，二级抗凝效果未持续

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content